{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:51:46Z","timestamp":1793407906956,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    A wide variety of mesenchymal lesions arise in the vulvovaginal region, some relatively site-specific. We report 4 cases of a novel vulvovaginal mesenchymal lesion, which we term vulvovaginal epithelioid mesenchymal neoplasm with \u201cdeciduoid\u201d morphology, reflecting the predominant morphologic feature of epithelioid cells with a granular glassy \u201cdeciduoid\u201d appearance. The tumors arose in women aged 34 to 48 years and involved the vagina (2 cases) or the vulval Bartholin\u2019s gland region (2 cases). The size ranged from 25 to 55\u00a0mm and they were solid and well-circumscribed. The tumors were composed of epithelioid and lesser numbers of spindle-shaped cells with abundant granular glassy eosinophilic cytoplasm, imparting a \u201cdeciduoid\u201d morphology; there was prominent vascularity and a mild lymphoid infiltrate. Immunohistochemistry showed consistent diffuse estrogen receptor, progesterone receptor, CD63, and vimentin positivity with no other consistent immunophenotype. Two of the tumors showed immunohistochemical BAP1 loss and exhibited inactivating germline\n                    <jats:italic toggle=\"yes\">BAP1<\/jats:italic>\n                    variants (BAP1 tumor predisposition syndrome). On molecular testing, all tumors showed copy number loss of genes in 14q and\/or 17q regions. Alterations of genes involved in the MAPK pathway were also present in all cases (including\n                    <jats:italic toggle=\"yes\">NF1<\/jats:italic>\n                    loss, a likely pathogenic variant in\n                    <jats:italic toggle=\"yes\">FLT3<\/jats:italic>\n                    , and variants of unknown significance in\n                    <jats:italic toggle=\"yes\">FLT3, BMPR1A<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">RUNX1<\/jats:italic>\n                    ). One of the cases harbored a novel\n                    <jats:italic toggle=\"yes\">FBXL20::MSI2<\/jats:italic>\n                    fusion. On follow-up (8\u00a0mo to 15\u00a0y), none of the tumors recurred. In reporting this novel neoplasm, we describe in detail the morphologic, immunohistochemical, and molecular features, discuss the differential diagnosis and histogenesis, and establish this novel entity as part of the BAP1 tumor predisposition syndrome.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002633","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T05:00:34Z","timestamp":1791781234000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Vulvovaginal Epithelioid Mesenchymal Neoplasm With \u201cDeciduoid\u201d Morphology"],"prefix":"10.1097","author":[{"given":"Andr\u00e1s","family":"R\u00f3kusz","sequence":"first","affiliation":[{"name":"Departments of Pathology and Experimental Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoma D.","family":"Attygalle","sequence":"additional","affiliation":[{"name":"Department of Histopathology, The Royal Marsden Hospital, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsombor","family":"Melegh","sequence":"additional","affiliation":[{"name":"Department of Surgical and Molecular Pathology, Centre of Tumour Pathology, National Institute of Oncology, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Scheich","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Experimental Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint Andr\u00e1s","family":"De\u00e1k","sequence":"additional","affiliation":[{"name":"Pathology, Forensic and Insurance Medicine, Semmelweis University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"H\u00f6lsken","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Erlangen (UKER), Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU)"},{"name":"Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"Vereczkey","sequence":"additional","affiliation":[{"name":"Department of Surgical and Molecular Pathology, Centre of Tumour Pathology, National Institute of Oncology, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Dezs\u0151","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Experimental Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Erlangen (UKER), Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU)"},{"name":"Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"R1-20261012","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2559.2008.03098.x","article-title":"Recent developments in vulvovaginal pathology","volume":"54","author":"McCluggage","year":"2009","journal-title":"Histopathology"},{"key":"R2-20261012","first-page":"26","article-title":"A review and update of morphologically bland vulvovaginal mesenchymal lesions","volume":"24","author":"McCluggage","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20261012","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.3390\/cancers15245892","article-title":"Determinants affecting the clinical implementation of a molecularly informed molecular tumor board recommendation: experience from a tertiary cancer center","volume":"15","author":"T\u00f6gel","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R4-20261012","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jmoldx.2026.03.004","article-title":"Oncogenicity Variant Interpreter (OncoVI) supports harmonized somatic variant interpretation in precision oncology","volume":"28","author":"Carta","year":"2026","journal-title":"J Mol Diagn"},{"key":"R5-20261012","doi-asserted-by":"crossref","first-page":"100750","DOI":"10.1016\/j.modpat.2025.100750","article-title":"The MEF2D::NCOA2 fusion defines a distinct emerging vulvovaginal myxoid epithelioid tumor with smooth muscle differentiation","volume":"38","author":"Trecourt","year":"2025","journal-title":"Mod Pathol"},{"key":"R6-20261012","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/PAS.0000000000000466","article-title":"Myoepithelioma-like tumors of the vulvar region: a distinctive group of SMARCB1-deficient neoplasms","volume":"39","author":"Yoshida","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R7-20261012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.path.2022.02.009","article-title":"Update on mesenchymal lesions of the lower female genital tract","volume":"15","author":"Croce","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"R8-20261012","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.pas.0000213360.03133.89","article-title":"Cellular neurothekeoma: detailed characterization in a series of 133 cases","volume":"31","author":"Hornick","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R9-20261012","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/PAI.0000000000000889","article-title":"Positive MITF and NKI\/C3 expression in cellular neurothekeoma and dermatofibroma","volume":"29","author":"Abdaljaleel","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R10-20261012","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1038\/s41598-025-98514-x","article-title":"Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumors","volume":"15","author":"Selt","year":"2025","journal-title":"Sci Rep"},{"key":"R11-20261012","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41379-021-00976-7","article-title":"Novel insights into the BAP1-inactivated melanocytic tumor","volume":"35","author":"Donati","year":"2022","journal-title":"Mod Pathol"},{"key":"R12-20261012","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/cge.14507","article-title":"BRCA1-associated protein 1: tumor predisposition syndrome and Kury-Isidor syndrome, from genotype-phenotype correlation to clinical management","volume":"105","author":"West","year":"2024","journal-title":"Clin Genet"},{"key":"R13-20261012","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"R14-20261012","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"R15-20261012","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"R16-20261012","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R18-20261012","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-026-04509-y","article-title":"Clinicopathological and molecular characteristics of rare ovarian sex cord stromal tumors with BAP1 mutation","author":"Li","year":"2026","journal-title":"Virchows Arch"},{"key":"R19-20261012","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PGP.0000000000000855","article-title":"BAP1 tumor predisposition syndrome presenting as a recurrent ovarian sex cord-stromal tumor","volume":"42","author":"Albright","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R20-20261012","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/PAS.0000000000002124","article-title":"Clinicopathologic analysis and molecular profiling of ovarian steroid cell tumors","volume":"47","author":"Mendoza","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R21-20261012","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-026-05445-2","article-title":"High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome","volume":"176","author":"Ramsey","year":"2026","journal-title":"J Neurooncol"},{"key":"R22-20261012","doi-asserted-by":"crossref","first-page":"588","DOI":"10.32074\/1591-951X-1659","article-title":"Immunohistochemical and molecular profiling of uveal melanoma: clinicopathological correlations from an Italian cohort","volume":"117","author":"Fortarezza","year":"2025","journal-title":"Pathologica"},{"key":"R23-20261012","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41431-024-01623-w","article-title":"Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series","volume":"32","author":"Miranda","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"R24-20261012","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/PAS.0000000000000907","article-title":"High-grade M\u00fcllerian adenosarcoma: genomic and clinicopathologic characterization of a distinct neoplasm with prevalent TP53 pathway alterations and aggressive behavior","volume":"41","author":"Hodgson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R25-20261012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.4442","article-title":"Targeted genomic analysis of M\u00fcllerian adenosarcoma","volume":"235","author":"Howitt","year":"2015","journal-title":"J Pathol"},{"key":"R26-20261012","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41379-022-01160-1","article-title":"Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors","volume":"35","author":"Momeni Boroujeni","year":"2022","journal-title":"Mod Pathol"},{"key":"R27-20261012","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jcp.2011.089664","article-title":"Unusual morphological features of uterine leiomyomas treated with progestogens","volume":"64","author":"Boyd","year":"2011","journal-title":"J Clin Pathol"},{"key":"R28-20261012","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","article-title":"Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion","volume":"97","author":"Cheek","year":"2020","journal-title":"Hum Pathol"},{"key":"R29-20261012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00004347-200201000-00009","article-title":"Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors","volume":"21","author":"Oliva","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R30-20261012","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PGP.0000000000000969","article-title":"\u201cDeciduoid\u201d change in uterine leiomyomas in pregnancy: aberrant expression of sex cord markers inhibin and calretinin","volume":"43","author":"Machuca-Aguado","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R31-20261012","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000002428","article-title":"Low-grade endometrial stromal sarcoma: clinicopathologic and prognostic features in a cohort of 102 tumors","volume":"49","author":"Devins","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R32-20261012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/his.14450","article-title":"Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms","volume":"80","author":"Papke","year":"2022","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T05:00:39Z","timestamp":1791781239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002633"}},"subtitle":["Report of a Novel Entity Frequently Associated With Inactivating Germline BAP1 Variants"],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002633","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"2026-07-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}